PNC Financial Services Group’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
DC
PNC Financial Services Group's FLGT Position: Q2 2026 in Review
PNC Financial Services Group reduced its Fulgent Genetics (FLGT) stake by 40% in Q2 2026, selling an estimated $4.93K and leaving 429 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4155.
PNC Financial Services Group first reported a position in FLGT in Q3 2020 and has held it in 24 quarters since. The position peaked at $356K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- PNC Financial Services Group held 429 shares of Fulgent Genetics worth $8.8K as of Q2 2026.
- PNC Financial Services Group sold 291 Fulgent Genetics shares in Q2 2026, an estimated $4.93K.
- Fulgent Genetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4155 holding.
- PNC Financial Services Group first reported a position in Fulgent Genetics in Q3 2020 and has held it in 24 quarters since.
- PNC Financial Services Group's Fulgent Genetics position peaked at $356K in Q4 2021.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.